Kadjo Claude Valéry Cédric Aka, Agbopanzo Ségla Achi Cédric, Offoumou Fiacre Delors, Aka Arlette Désirée
Service de neurologie, Centre hospitalier universitaire (CHU) de Cocody, Université Félix Houphouët Boigny, UFR des sciences médicales d'Abidjan, Cote d'Ivoire.
Med Trop Sante Int. 2024 Nov 15;4(4). doi: 10.48327/mtsi.v4i4.2024.543. eCollection 2024 Dec 31.
Thyrotoxic hypokalemic periodic paralysis (THPP) is a sporadic form of hypokalemic periodic paralysis (HPP). It is a diagnostic and therapeutic emergency rarely described in the black population. We report a case in a black subject from Côte d'Ivoire.
Mr. NK, 37 years old, was admitted to hospital with rapidly progressive motor deficit in all four limbs. The patient had hyperthyroidism, which was treated with neomercazole. His medical history revealed an initial episode that resolved within 30 minutes, followed by a more severe recurrence 4 months later, associated with discontinuation of treatment. Clinical examination revealed flaccid tetraparesis mainly affecting the lower limbs. Biological tests showed hypokalemia of 2.6 mEq/L, ultrasensitive TSH was low (less than 0.005 µL/mL) with T3 and T4 elevations of 24.42 µL/mL and 79.68 µL/mL respectively. We have retained the diagnosis of THPP. The clinical course was satisfactory after correction of the kalemia and readjustment of the hyperthyroidism treatment.
THPP is common in young Asians and rare in black Africans. The duration of paralysis varies from 1 to 72 hours, with an average of almost 24 hours. Respiratory paralysis, which is potentially serious, is rare. However, discontinuation of treatment in patients already on the drug may predispose to paralysis.
The favorable evolution of paralysis after correction of kalemia was confirmed. Our observation highlights the importance of maintaining good thyroid function in patients monitored for hyperthyroidism.
甲状腺毒症性低钾性周期性麻痹(THPP)是低钾性周期性麻痹(HPP)的一种散发性形式。这是一种在黑人人群中很少被描述的诊断和治疗紧急情况。我们报告了一例来自科特迪瓦的黑人患者的病例。
NK先生,37岁,因四肢迅速进展的运动功能障碍入院。该患者患有甲状腺功能亢进症,用甲巯咪唑进行治疗。他的病史显示最初一次发作在30分钟内缓解,4个月后更严重地复发,与治疗中断有关。临床检查显示弛缓性四肢轻瘫,主要影响下肢。生物学检查显示低钾血症,血钾为2.6 mEq/L,超敏促甲状腺激素水平低(低于0.005 μL/mL),T3和T4分别升高至24.42 μL/mL和79.68 μL/mL。我们确诊为THPP。在纠正血钾和重新调整甲状腺功能亢进症治疗后,临床病程令人满意。
THPP在年轻亚洲人中常见,在非洲黑人中罕见。麻痹持续时间从1至72小时不等,平均约24小时。潜在严重的呼吸麻痹很少见。然而,已在用药的患者中断治疗可能易导致麻痹。
血钾纠正后麻痹的良好转归得到证实。我们的观察突出了在监测甲状腺功能亢进症患者中维持良好甲状腺功能的重要性。